Financing, Equity Capital Markets

Poseida Therapeutics, Inc.

07/20
|
$224.0 Million
Piper Sandler served as bookrunner for Poseida Therapeutics, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma